Serum vascular endothelial growth factors C and D in patients with oesophageal cancer

European Journal of Cardio-thoracic Surgery

Volumn 38, Issue 3, 2010, Pages 260-267

  Kozlowski, Miroslaw ^a   Kowalczuk, Oksana ^a   Milewski, Robert ^a   Chyczewski, Lech ^a   Niklinski, Jacek ^a   Laudański, Jerzy ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Lymph nodes metastases; Oesophageal cancer; Prognosis; Serum VEGF C; Serum VEGF D

Indexed keywords

VASCULOTROPIN C; VASCULOTROPIN D;

ADULT; ARTICLE; CANCER STAGING; CANCER SURGERY; CONTROLLED STUDY; DISTANT METASTASIS; ENZYME LINKED IMMUNOSORBENT ASSAY; ESOPHAGUS CANCER; ESOPHAGUS DISEASE; FEMALE; HISTOPATHOLOGY; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL TIME; TUMOR VOLUME;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; DIAGNOSIS, DIFFERENTIAL; EPIDEMIOLOGIC METHODS; ESOPHAGEAL DISEASES; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASM STAGING; PROGNOSIS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR C; VASCULAR ENDOTHELIAL GROWTH FACTOR D;

EID: 77955924562     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2010.01.061     Document Type: Article

References (25)

1. Crew K.D., Neugut A. Epidemiology of upper gastrointestinal malignancies. Semin Oncol 2004, 31:450-464.
2. Kato H., Kimura H., Nakajima M., Sakai M., Sano A., Tanaka N., Inose T., Faried A., Saito K., Ieta K., Sohda M., Fukai Y., Miyazaki T., Masuda N., Fukuchi M., Ojima H., Tsukada K., Oriuchi N., Endo K., Kuwano H. The additional value of integrated PET/CT over PET in initial lymph node staging of esophageal cancer. Oncol Rep 2008, 20:857-862.
3. Kosugi S., Nishimaki T., Kanda T., Nakagawa S., Ohashi M., Hatakeyama K. Clinical significance of serum carcinoembryonic antigen, carbohydrate antigen 19-9, and squamous cell carcinoma antigen levels in esophageal cancer patients. World J Surg 2004, 28:680-685.
4. Sobin L.H., Wittekind C. International Union Against Cancer (UICC) TNM classification of malignant tumors 2002, Wiley-Liss, New York. 6th ed.
5. Tachibana M., Kinugasa S., Hirahara N., Yoshimura H. Lymph node classification of esophageal squamous cell carcinoma and adenocarcinoma. Eur J Cardiothoracic Surg 2008, 34:427-431.
6. Nathanson S.D. Insight into the mechanisms of lymph node metastasis. Cancer 2003, 98:413-423.
7. Stacker S.A., Achen M.G., Jussila L., Baldwin M.E., Alitalo K. Lymphangiogenesis and cancer metastasis. Nat Rev Cancer 2002, 2:573-583.
8. Kleespies A., Bruns C.J., Jauch K.W. Clinical significance of VEGF-A, -C and -D expression in esophageal malignancies. Onkologie 2005, 28:281-288.
9. Mandriota S.J., Jussila L., Jeltsch M., Compagni A., Baetens D., Prevo R., Banerji S., Huarte J., Montesano R., Jackson D.G., Orci L., Alitalo K., Christofori G., Pepper M.S. Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis. EMBO J 2001, 20:672-682.
10. Kitadai Y., Amioka T., Haruma K., Tanaka S., Yoshihara M., Sumii K., Matsutani N., Yasui W., Chayama K. Clinicopathological significance of vascular endothelial growth factor (VEGF)-C in human esophageal squamous cell carcinomas. Int J Cancer 2001, 93:662-666.
11. Boone B., Blokx W., De Bacquer D., Lambert J., Ruiter D., Brochez L. The role of VEGF-C staining in predicting regional metastasis in melanoma. Virchows Arch 2008, 453:257-265.
12. Tzao C., Lee S.C., Tung H.J., Hsu H.S., Hsu W.H., Sun G.H., Yu C.P., Jin J.S., Cheng Y.L. Expression of hypoxia-inducible factor (HIF)-1alpha and vascular endothelial growth factor (VEGF)-D as outcome predictors in resected esophageal squamous cell carcinoma. Dis Markers 2008, 25:141-148.
13. Tsirlis T.D., Papastratis G., Masselou K., Tsigris C., Papachristodoulou A., Kostakis A., Nikiteas N.I. Circulating lymphangiogenic growth factors in gastrointestinal solid tumors, could they be of any clinical significance?. World J Gastroenterol 2008, 14:2691-2701.
14. Mitsuhashi A., Suzuka K., Yamazawa K., Matsui H., Seki K., Sekiya S. Serum vascular endothelial growth factor (VEGF) and VEGF-C levels as tumor markers in patients with cervical carcinoma. Cancer 2005, 103:724-730.
15. Naumnik W., Izycki T., Swidzińska E., Ossolińiska M., Chyczewska E. Serum levels of VEGF-C, VEGF-D, and sVEGF-R2 in patients with lung cancer during chemotherapy. Oncol Res 2007, 16:445-451.
16. Krzystek-Korpacka M., Matusiewicz M., Diakowska D., Grabowski K., Blachut K., Banas T. Up-regulation of VEGF-C secreted by cancer cells and not VEGF-A correlates with clinical evaluation of lymph node metastasis in esophageal squamous cell carcinoma (ESCC). Cancer Lett 2007, 249:171-177.
17. Kimura H., Kato H., Tanaka N., Inose T., Faried A., Sohda M., Nakajima M., Fukai Y., Miyazaki T., Masuda N., Manda R., Fukuchi M., Ojima H., Tsukada K., Kuwano H. Preoperative serum vascular endothelial growth factor-C (VEGF-C) levels predict recurrence in patients with esophageal cancer. Anticancer Res 2008, 28:165-169.
18. Wang T.B., Deng M.H., Qiu W.S., Dong W.G. Association of serum vascular endothelial growth factor-C and lymphatic vessel density with lymph node metastasis and prognosis of patients with gastric cancer. World J Gastroenterol 2007, 13:1794-1797.
19. Al-Moundhri M.S., Al-Shukaili A., Al-Nabhani M., Al-Bahrani B., Burney I.A., Rizivi A., Ganguly S.S. Measurement of circulating levels of VEGF-A, -C, and -D and their receptors, VEGFR-1 and -2 in gastric adenocarcinoma. World J Gastroenterol 2008, 14:3879-3883.
20. Kimura Y., Watanabe M., Ohga T., Saeki H., Kakeji Y., Baba H., Maehara Y. Vascular endothelial growth factor C expression correlates with lymphatic involvement and poor prognosis in patients with esophageal squamous cell carcinoma. Oncol Rep 2003, 10:1747-1751.
21. Matsumoto M., Natsugoe S., Okumura H., Arima H., Yanagita S., Uchikado Y., Yokomakura N., Setoyama T., Ishigami S., Takao S., Aikou T. Overexpression of vascular endothelial growth factor-C correlates with lymph node micrometastasis in submucosal esophageal cancer. J Gastrointest Surg 2006, 10:1016-1022.
22. Noguchi T., Takeno S., Shibata T., Uchida Y., Yokoyama S., Müller W. VEGF-C, expression correlates with histological differentiation and metastasis in squamous cell carcinoma of the esophagus. Oncol Rep 2002, 9:995-999.
23. Tamura M., Oda M., Tsunezuka Y., Matsumoto I., Kawakami K., Ohta Y., Watanabe G. Chest CT and serum vascular endothelial growth factor-C level to diagnose lymph node metastasis in patients with primary non-small cell lung cancer. Chest 2004, 126:342-346.
24. Yu X.M., Lo C.Y., Lam A.K., Leung P., Luk J.M. Serum vascular endothelial growth factor C correlates with lymph node metastases and high-risk tumor profiles in papillary thyroid carcinoma. Ann Surg 2008, 247:483-489.
25. Okazawa T., Yoshida T., Shirai Y., Shiraishi R., Harada T., Sakaida I., Abe T., Oka M. Expression of vascular endothelial growth factor C is a prognostic indicator in esophageal cancer. Hepatogastroenterology 2008, 55:1503-1508.